# US Mastitis Market

> US Mastitis Market Research Report: Size, Share, Trend Analysis By Types (Contagious Mastitis, Environmental Mastitis, Opportunist Mastitis, Non-Infectious Mastitis, Infectious Mastitis), By Treatment (Antibiotics, Vaccines, Pain Relievers) and By End Users (Veterinary Centers, Hospital & Clinics) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 17.43%
- **2024:** $ 5.79 Billion
- **2025:** $ 6.8 Billion
- **2035:** $ 33.91 Billion
- **Key Players:** Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Cegelec (FR), Vetoquinol (FR), Huvepharma (BG), Dechra Pharmaceuticals (GB), Phibro Animal Health (US)

**Report ID:** MRFR/Pharma/11749-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-mastitis-market-13274

---

## Market Summary

## **US Mastitis Market Overview**

**As per MRFR analysis, the US Mastitis Market Size was estimated at 4.96 (USD Billion) in 2023. The US Mastitis Market Industry is expected to grow from 5.5(USD Billion) in 2024 to 9.5 (USD Billion) by 2035. The US Mastitis Market CAGR (growth rate) is expected to be around 5.094% during the forecast period (2025 - 2035).**

### **Key US Mastitis Market Trends Highlighted**

The US Mastitis Market is experiencing noteworthy trends, driven by a growing awareness of animal health and optimal dairy production. Key market drivers include the increasing demand for high-quality milk and dairy products. As consumers prioritize nutritional value, dairy farmers are investing in better herd management practices, which directly influences the need for effective mastitis treatment solutions.

Additionally, the rising prevalence of [mastitis](../../../reports/mastitis-market-5379) in dairy cattle has prompted a shift towards innovative solutions to prevent and manage this condition. Opportunities in the US Mastitis Market are expanding, particularly as the dairy industry focuses on sustainability and animal welfare. This shift opens doors for new products that offer both efficacy and environmental safety, including alternative therapies and preventative measures.

The integration of technology, such as monitoring systems and data analytics, provides dairy farmers with tools to identify early signs of mastitis, further enhancing herd health and productivity. Recent trends highlight an increasing collaboration between veterinary services and dairy producers, which enhances the overall approach to mastitis management. Education and training initiatives are also underway, aimed at raising awareness among farmers about the importance of timely intervention and proper milking procedures.

Consequently, this collaborative approach not only advances treatment pathways but also fosters a culture of proactive health management within the dairy industry. The convergence of technology, education, and demand for quality dairy reinforces the dynamic development of the US Mastitis Market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Mastitis Market Drivers**

### **Increasing Incidence of Mastitis in Dairy Cattle**

The US Mastitis Market Industry is significantly driven by the increasing incidence of mastitis in dairy cattle. According to the United States Department of Agriculture (USDA), mastitis accounts for around 40% of all dairy cow health issues, with each case resulting in considerable financial loss for farmers due to decreased milk production and increased veterinary costs.

Research has indicated that the prevalence of mastitis in dairy herds can lead to economic losses ranging from 200 to 300 USD per cow annually. This emphasizes the necessity for effective treatment solutions and preventative measures, which in turn promotes growth in the US Mastitis Market.

As producers are becoming more aware of the impact of mastitis on profitability, there is an increasing demand for innovative therapies, such as antimicrobial drugs and vaccination programs, to tackle the problem. The increasing focus on herd health management by established organizations like the American Association of Bovine Practitioners has also heightened industry awareness and awareness regarding the significance of managing mastitis.

### **Advancements in Diagnostics and Treatment Solutions**

The US Mastitis Market Industry is being propelled by advancements in diagnostic technologies and treatment solutions for mastitis. The development of rapid diagnostic tests enables farmers and veterinarians to quickly identify mastitis pathogens, leading to timely and appropriate treatment interventions. The introduction of novel treatment protocols utilizing antimicrobials and alternative therapies is transforming the management practices for mastitis.

Prominent agricultural technology firms have invested heavily in Research and Development (R&D) for innovative products, resulting in effective solutions that are driving market growth. For instance, the National Dairy FARM (Farmers Assuring Responsible Management) program emphasizes the need for evidence-based practices in managing mastitis, including the implementation of improved diagnostic methodologies.

This has encouraged dairy producers to adopt new technologies, enhancing overall herd health and increasing production efficiency.

### **Rising Awareness about Animal Welfare**

The US Mastitis Market Industry benefits from the growing awareness of animal welfare, leading to increased scrutiny of dairy farming practices. According to the American Veterinary Medical Association (AVMA), consumers are increasingly concerned about the humane treatment of farm animals, influencing the dairy industry's practices and encouraging farmers to adopt better management practices that prevent mastitis.

This rising demand for ethically produced dairy products has prompted farmers to implement animal welfare programs that monitor and improve cow health, thereby reducing complications associated with mastitis. As a result, there is a rising market for preventative health measures, educational programs, and treatments that align with animal welfare standards, ultimately fostering growth in the US Mastitis Market.

## **US Mastitis Market Segment Insights**

### **Mastitis Market Type Insights**

The US Mastitis Market has demonstrated significant segmentation based on the type of mastitis, with each category addressing unique pathogens and treatment demands in the dairy industry. Contagious Mastitis is a leading type known for high transmission rates among dairy herds, primarily caused by bacteria such as Streptococcus agalactiae and Staphylococcus aureus. This presents challenges for livestock management, requiring strict biosecurity measures and effective milking hygiene practices.

Environmental Mastitis, often linked to pathogens found in the cow's environment, particularly thrives in less sanitary conditions, making control imperative for herd health and productivity. The rising focus on improved farm management practices and cleaner living conditions is crucial in reducing instances of this type. Opportunist Mastitis, while typically less common, can occur due to various bacteria acting on compromised health; thus, monitoring cow health remains paramount to minimizing these occurrences.

Non-Infectious Mastitis distinguishes itself through factors such as trauma or chemical irritants rather than infections, highlighting the necessity for comprehensive management strategies that emphasize cow comfort and welfare. Infectious Mastitis, as a broad classification, underscores both environmental and contagious infections, where the need for robust testing and results-driven treatment protocols stands out.

As these types reveal the diverse causes and implications of mastitis, understanding their characteristics is essential for the US Mastitis Market statistics, guiding research and development efforts aimed at enhancing dairy health and industry standards. Overall, the segmentation by type is not only fundamental for tailoring interventions but is also a driver for advancements in treatment and prevention efforts, establishing a solid foundation for the growth and evolution of the market. Each type contributes to the overarching goal of optimizing herd health, enhancing milk production efficiency, and ultimately fostering a sustainable dairy industry environment within the US.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Mastitis Market Treatment Insights**

The Treatment segment of the US Mastitis Market plays a crucial role in addressing this prevalent condition among dairy livestock. With the increasing focus on animal health and productivity, Antibiotics remain a primary choice for veterinarians due to their effectiveness in combating bacterial infections, which are a significant cause of mastitis in dairy cattle.

Vaccines are gaining traction as a preventive measure, aiming to bolster the immune response in herds and reduce the incidence of mastitis, thereby enhancing herd health and economic returns for farmers. Pain Relievers are essential for managing discomfort in affected animals, improving their overall welfare and productivity. The growing awareness of mastitis impacts on milk quality and economic losses further drives the demand within this segment.

Overall, innovations and advancements in treatment methodologies are observed, contributing positively to the market growth, making it a pivotal area of focus within the US Mastitis Market landscape.

### **Mastitis Market End User Insights**

The End User segment of the US Mastitis Market is crucial for understanding the distribution of veterinary services and healthcare interventions tailored for mastitis management. Veterinary Centers play a significant role in providing specialized diagnoses and treatments, catering primarily to livestock and dairy farmers who face challenges related to mastitis. These centers are equipped with advanced technologies and skilled professionals to ensure effective disease management, significantly impacting milk production quality and herd health.

Additionally, Hospitals and Clinics are pivotal for handling more complex cases, providing a range of diagnostic tools, therapies, and surgical options that help mitigate mastitis in both large and small agricultural operations. The growing adoption of preventive measures and frequent consultations in these end-user facilities is vital for controlling mastitis, leading to improved animal welfare and economic benefits for farmers.

As the US dairy industry emphasizes milk quality and health standards, the importance of these end user categories continues to grow, making them indispensable in the ongoing fight against mastitis. Overall, the insights reveal that addressing mastitis through these platforms is integral for sustaining productivity and enhancing agricultural practices across the nation.

## **US Mastitis Market Key Players and Competitive Insights**

The US Mastitis Market has gained significant attention in recent years due to the increasing prevalence of mastitis among dairy cattle, which necessitates effective management solutions to ensure animal health and optimize milk production. As dairy farms continue to intensify and embrace technology, the competition in this market has become aggressive. Numerous players are innovating their product offerings, ranging from antibiotics and anti-inflammatory agents to diagnostic tools and prevention strategies.

This competitive landscape is shaped by the demand for sustainable practices, stringent regulatory policies, and a growing awareness of animal welfare. As a result, companies are continuously evolving their strategies to enhance their market share and improve overall product efficacy in addressing mastitis. Within this competitive realm, Genus has established a strong presence in the US Mastitis Market.

This company is recognized for its dedication to agricultural biotechnology and its role in advancing genetic solutions aimed at enhancing livestock productivity and health. Genus’s strengths lie in its innovative breeding technologies and robust research and development initiatives, which enable it to provide valuable genetic assets tailored for dairy operations. By leveraging its expertise in genomics, Genus has been able to create livestock that is less susceptible to mastitis, thereby improving disease resistance in dairy herds.

This strategic focus on genetic health and resilience has positioned Genus favorably against competitors, allowing it to cater to the evolving needs of dairy farmers in the US. Vetoquinol also plays a significant role in the US Mastitis Market, offering a range of veterinary products and services focused on promoting animal health. Key offerings from Vetoquinol include anti-mastitis treatments, milking hygiene solutions, and nutritional supplements designed to enhance the wellbeing of dairy cattle and reduce the incidence of mastitis.

The company boasts a well-established market presence, supported by an extensive distribution network that ensures product accessibility to dairy farmers. Vetoquinol's strengths are highlighted by its strong research foundation, commitment to innovation, and a focus on customer education regarding best practices in mastitis management. Additionally, Vetoquinol has engaged in strategic collaborations and acquisitions, enhancing its product portfolio and fostering advancements in veterinary care within the US market. The combination of these attributes solidifies Vetoquinol’s position as a key player in addressing the challenges posed by mastitis among dairy herds in the region.

### **Key Companies in the US Mastitis Market Include**

## **US Mastitis Market Industry Developments**

Recent developments in the US Mastitis Market indicate a dynamic and evolving landscape, with continued focus on combating this significant dairy cattle health issue. Companies such as Zoetis, Merck Animal Health, and Elanco Animal Health have been actively engaging in Research and Development to enhance treatment options for mastitis, which is critical for maintaining herd health and productivity.

In August 2023, Genus announced a partnership with Alltech for the implementation of microbiome-based solutions aimed at reducing cases of mastitis. Reports also indicate a growing trend towards the use of advanced probiotics and vaccines to address mastitis, showcasing innovations from firms like Vetoquinol and Boehringer Ingelheim.

In terms of financial movement, the valuation of companies involved in the US Mastitis Market has shown considerable growth due to rising awareness of animal health and welfare. Over the past few years, the market has witnessed a steady increase in investments and mergers, with notable activities reported, such as Westway Feed Products seeking to enhance its product line through a strategic acquisition in July 2022.

Additionally, the Agricultural Research Service has implemented programs aimed at improving early detection and treatment methodologies, further solidifying the proactive approach within the market.

## **US Mastitis Market Segmentation Insights**

### **Mastitis Market Type Outlook**

### **Mastitis Market Treatment Outlook**

### **Mastitis Market End User Outlook**

- Veterinary Centers
- Hospital & Clinics

## Market Drivers

### Increasing Awareness of Animal Health

The mastitis market is experiencing a surge in awareness regarding animal health, particularly among dairy farmers. This heightened consciousness is driven by educational initiatives and outreach programs aimed at promoting best practices in herd management. As farmers become more informed about the implications of mastitis on milk production and animal welfare, they are more likely to invest in preventive measures and treatment options. This trend is reflected in the growing demand for veterinary services and products designed to combat mastitis. In 2025, the market for mastitis-related products is projected to reach approximately $1.5 billion in the US, indicating a robust growth trajectory fueled by this increased awareness.

### Regulatory Support for Animal Welfare

The mastitis market is influenced by increasing regulatory support aimed at enhancing animal welfare standards. In the US, various governmental bodies are implementing stricter regulations regarding the treatment and prevention of mastitis in dairy cattle. These regulations often require farmers to adopt more humane and effective practices, which in turn drives the demand for advanced mastitis management solutions. Compliance with these regulations necessitates investment in better diagnostic and treatment options, thereby propelling market growth. The financial implications of non-compliance can be substantial, further motivating farmers to prioritize mastitis management. This regulatory environment is expected to contribute to a market valuation of approximately $1.8 billion by 2026.

### Rising Demand for Organic Dairy Products

The mastitis market is experiencing a shift in consumer preferences towards organic dairy products. As consumers become more health-conscious, there is a growing demand for milk and dairy products that are produced without the use of antibiotics and hormones. This trend is prompting dairy farmers to adopt more stringent mastitis management practices to ensure compliance with organic certification standards. Consequently, the market for mastitis management solutions is likely to expand as farmers seek effective ways to maintain herd health while meeting organic production requirements. The organic dairy segment is projected to grow at a CAGR of 8% over the next five years, indicating a robust opportunity for the mastitis market.

### Economic Impact of Mastitis on Dairy Production

The mastitis market is significantly affected by the economic implications of mastitis on dairy production. Mastitis not only leads to decreased milk yield but also increases veterinary costs and reduces the overall profitability of dairy operations. The financial burden associated with mastitis can be substantial, with estimates suggesting that it costs the US dairy industry over $2 billion annually. This economic impact drives farmers to seek effective solutions for mastitis prevention and treatment, thereby stimulating growth in the mastitis market. As awareness of these economic factors continues to rise, investments in mastitis management technologies and practices are expected to increase, further propelling market expansion.

### Technological Advancements in Treatment Options

The mastitis market is witnessing significant advancements in treatment technologies, which are reshaping the landscape of mastitis management. Innovations such as targeted therapies and improved formulations of existing treatments are becoming more prevalent. These advancements not only enhance the efficacy of mastitis treatments but also reduce the time required for recovery, thereby minimizing economic losses for dairy farmers. The introduction of new diagnostic tools that allow for quicker identification of mastitis cases is also contributing to this trend. As a result, the market is expected to grow at a CAGR of around 6% over the next five years, reflecting the impact of these technological improvements on the mastitis market.

## Future Outlook

The [Mastitis Market](https://www.marketresearchfuture.com/reports/mastitis-market-5379) is projected to grow at a 17.43% CAGR from 2025 to 2035, driven by advancements in treatment technologies and increasing awareness among dairy farmers.

**New opportunities:**

- Development of mobile diagnostic tools for early mastitis detection. Investment in automated milking systems to reduce infection rates. Expansion of telehealth services for veterinary consultations on mastitis management.

By 2035, the mastitis market is expected to achieve substantial growth, driven by innovative solutions and increased market demand.

## Segment Insights

### By Type: Bovine Contagious Mastitis (Largest) vs. Bovine Environmental Mastitis (Fastest-Growing)

The market share distribution in the US mastitis market shows that Bovine Contagious Mastitis holds the largest share, reflecting its significant impact on dairy production and animal health. In contrast, Bovine Environmental Mastitis is emerging rapidly, contributing to an increasing share of the market due to heightened awareness about environmental factors affecting bovine health and productivity.

Growth trends indicate that while Bovine Contagious Mastitis remains dominant due to ongoing veterinary attention and treatment advancements, Bovine Environmental Mastitis is witnessing the fastest growth driven by rising investments in preventive measures and better management practices. The awareness campaigns focused on environmental hygiene and milking practices are also contributing to this upward trend.

Bovine Contagious Mastitis (Dominant) vs. Bovine Environmental Mastitis (Emerging)

Bovine Contagious Mastitis is characterized by a persistent prevalence among dairy herds, often linked to pathogens transmitted between animals. It necessitates robust interventions for effective management and control, which enhances its dominant market position. On the other hand, Bovine Environmental Mastitis, caused by pathogens in the cow's environment, is an emerging concern as it has gained significant focus recently due to the emphasis on improving overall farm hygiene. Both segments play crucial roles in shaping treatment strategies, but the growing recognition of environmental influence on mastitis prevalence is rapidly changing market dynamics.

### By Treatment: Bovine Antibiotics (Largest) vs. Bovine Vaccines (Fastest-Growing)

Within the treatment segment of the US mastitis market, Bovine Antibiotics dominate the landscape, comprising a substantial portion of the overall market share. This segment's significance is largely attributed to its established usage in mastitis management, with veterinarians frequently prescribing antibiotics to treat infections in dairy cattle, ensuring the health and productivity of the herd.

Conversely, Bovine Vaccines are emerging as the fastest-growing segment, driven by an increasing awareness of the preventive measures against mastitis. The demand for vaccines is gaining traction due to the growing emphasis on herd health and the push for antibiotic stewardship among livestock producers. This growth is likely to be supported by advancements in vaccine development, resulting in more effective immunization strategies.

Bovine Antibiotics (Dominant) vs. Bovine Vaccines (Emerging)

Bovine Antibiotics play a dominant role in the US mastitis market due to their critical function in treating infected dairy cattle, thereby reducing the economic impact of mastitis on farms. This segment includes various formulations, such as intramammary and systemic antibiotics, tailored to effectively combat mastitis. On the other hand, Bovine Vaccines are gaining ground as an emerging solution. They are designed not only to prevent mastitis but also to improve the overall health and milk production of dairy herds. The growing demand for sustainable farming practices is intensifying interest in vaccines, leading to increased research and development efforts in this area, thereby positioning Bovine Vaccines as a viable alternative to antibiotics.

### By End User: Veterinary Centers (Largest) vs. Hospital & Clinics (Fastest-Growing)

In the US mastitis market, the distribution of market share among the end user segments reveals that Veterinary Centers hold a significant portion of the market, reflecting their vital role in the treatment and management of mastitis. These centers are equipped with specialized knowledge and tools to diagnose and treat mastitis effectively, catering to a broad client base of livestock producers and dairy farmers.

On the other hand, Hospital & Clinics are emerging as the fastest-growing segment within this market. This surge can be attributed to the increasing awareness of mastitis management, advancements in veterinary medicine, and a rising number of veterinary professionals opting to work in clinical settings. The integration of new treatment modalities and enhanced veterinary services is strengthening the foothold of this segment in the marketplace.

Veterinary Centers (Dominant) vs. Hospital & Clinics (Emerging)

Veterinary Centers are positioned as the dominant players in the US mastitis market, offering comprehensive services that address the needs of both small and large-scale dairy operations. They provide specialized care, diagnostic services, and treatments tailored to manage mastitis, usually employing advanced techniques that ensure effective results. This segment is characterized by a strong focus on customer relationships and long-term partnerships with dairy producers. Conversely, Hospitals & Clinics represent an emerging segment that is gaining traction due to the increasing demand for specialized veterinary care. They are expanding their services to include innovative treatment approaches and preventive care, driven by the growing recognition of the economic impact of mastitis on dairy profitability. These facilities are increasingly adopting modern technology to improve treatment efficacy and enhance patient outcomes.

## Competitive Benchmarking

The mastitis market exhibits a competitive landscape characterized by a blend of innovation, strategic partnerships, and a focus on sustainability. Key players such as Zoetis (US), Merck Animal Health (US), and Elanco Animal Health (US) are at the forefront, each employing distinct strategies to enhance their market presence. Zoetis (US) emphasizes innovation in product development, particularly in the realm of vaccines and diagnostics, which appears to be a critical driver of their growth. Meanwhile, Merck Animal Health (US) focuses on expanding its portfolio through strategic acquisitions, thereby enhancing its capabilities in addressing mastitis. Elanco Animal Health (US) is also notable for its commitment to sustainability, integrating environmentally friendly practices into its operations, which resonates well with current market demands.The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market needs. The competitive structure of the mastitis market is moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Zoetis (US) and Merck Animal Health (US) suggests a trend towards consolidation, as these firms leverage their resources to gain a competitive edge.
In October Zoetis (US) announced a partnership with a leading agricultural technology firm to develop a digital platform aimed at improving mastitis detection and management on dairy farms. This strategic move is likely to enhance Zoetis's product offerings and position them as a leader in digital solutions within the mastitis market. The integration of technology into traditional veterinary practices could significantly improve outcomes for dairy farmers, thereby reinforcing Zoetis's market position.
In September Merck Animal Health (US) completed the acquisition of a smaller biotech company specializing in mastitis treatment solutions. This acquisition is expected to bolster Merck's product pipeline and expand its reach in the mastitis segment, indicating a proactive approach to enhancing its competitive stance. By integrating innovative treatments into its portfolio, Merck is likely to address unmet needs in the market, thereby attracting a broader customer base.
In August Elanco Animal Health (US) launched a new line of sustainable mastitis treatment products, which are designed to minimize environmental impact while maintaining efficacy. This initiative aligns with the growing consumer demand for sustainable agricultural practices and positions Elanco favorably among environmentally conscious consumers. The launch reflects a broader trend in the industry towards sustainability, which is becoming a key differentiator in the market.
As of November the mastitis market is increasingly defined by trends such as digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and enhancing product offerings. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet evolving consumer expectations and regulatory standards.

## Recent News & Developments

Recent developments in the US Mastitis Market indicate a dynamic and evolving landscape, with continued focus on combating this significant dairy cattle health issue. Companies such as Zoetis, Merck Animal Health, and Elanco Animal Health have been actively engaging in Research and Development to enhance treatment options for mastitis, which is critical for maintaining herd health and productivity.

In August 2023, Genus announced a partnership with Alltech for the implementation of microbiome-based solutions aimed at reducing cases of mastitis. Reports also indicate a growing trend towards the use of advanced probiotics and vaccines to address mastitis, showcasing innovations from firms like Vetoquinol and Boehringer Ingelheim.

In terms of financial movement, the valuation of companies involved in the US Mastitis Market has shown considerable growth due to rising awareness of animal health and welfare. Over the past few years, the market has witnessed a steady increase in investments and mergers, with notable activities reported, such as Westway Feed Products seeking to enhance its product line through a strategic acquisition in July 2022.

Additionally, the Agricultural Research Service has implemented programs aimed at improving early detection and treatment methodologies, further solidifying the proactive approach within the market.

## Report Scope

| MARKET SIZE 2024 | 5.79(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.8(USD Billion) |
| MARKET SIZE 2035 | 33.91(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 17.43% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Cegelec (FR), Vetoquinol (FR), Huvepharma (BG), Dechra Pharmaceuticals (GB), Phibro Animal Health (US) |
| Segments Covered | Type, Treatment, End User |
| Key Market Opportunities | Advancements in diagnostic technologies enhance early detection and treatment options in the mastitis market. |
| Key Market Dynamics | Rising demand for innovative treatments drives competition and regulatory scrutiny in the mastitis market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US mastitis market in 2024?**
A: The market valuation of the US mastitis market was $5.79 Billion in 2024.

**Q: What is the projected market valuation for the US mastitis market by 2035?**
A: The projected market valuation for the US mastitis market is $33.91 Billion by 2035.

**Q: What is the expected CAGR for the US mastitis market during the forecast period 2025 - 2035?**
A: The expected CAGR for the US mastitis market during the forecast period 2025 - 2035 is 17.43%.

**Q: Which companies are considered key players in the US mastitis market?**
A: Key players in the US mastitis market include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, and others.

**Q: What are the main segments of the US mastitis market?**
A: The main segments of the US mastitis market include Bovine Contagious Mastitis, Bovine Environmental Mastitis, and Human Infectious Mastitis.

**Q: What was the valuation of Bovine Antibiotics in the US mastitis market?**
A: The valuation of Bovine Antibiotics in the US mastitis market was $2.5 Billion in 2024.

**Q: How much is the Bovine Contagious Mastitis segment valued at?**
A: The Bovine Contagious Mastitis segment was valued at $1.15 Billion in 2024.

**Q: What is the projected growth for the Bovine Environmental Mastitis segment by 2035?**
A: The Bovine Environmental Mastitis segment is projected to grow to $5.9 Billion by 2035.

**Q: What are the end-user segments in the US mastitis market?**
A: End-user segments in the US mastitis market include Veterinary Centers and Hospitals & Clinics.

**Q: What was the valuation of the Veterinary Centers segment in 2024?**
A: The valuation of the Veterinary Centers segment was $2.89 Billion in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-mastitis-market-13274*